Towards a sustainable European vaccine infrastructure
TIMELINE
01 June 2020 to 31 May 2022
FUNDING
1.88 M Euro
TRANSVAC-DS aims to consolidate the conceptual and technical design and ultimate implementation of a European vaccine R&D infrastructure.
TRANSVAC-DS Work package structure and flow:
Work packages
WP
Input
Feasibly
and
option analysis
Gaps & needs analysis and context analysis of research infrastructure landscape
Stakeholder engagement startegy
Socio-economic impact analysis
Ethics
Communication and Dissemination
Recent News:
Rapid progress towards the development of potent vaccines can only happen through concerted and coordinated efforts in Europe and Worldwide.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 951668.
Apply for Vaccine R&D services and Training:
Connect
